Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results …

…, HMC Scarth, DM Mammolito, DR McCready… - The lancet …, 2007 - thelancet.com
Background The goals of axillary-lymph-node dissection (ALND) are to maximise survival,
provide regional control, and stage the patient. However, this technique has substantial side-…

[HTML][HTML] Regional nodal irradiation in early-stage breast cancer

…, P Craighead, J Bowen, DR McCready… - … England Journal of …, 2015 - Mass Medical Soc
Background Most women with breast cancer who undergo breast-conserving surgery receive
whole-breast irradiation. We examined whether the addition of regional nodal irradiation to …

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival

…, S Odorcic, L Chang, H Zhang, N Miller, DR McCready… - Cancer research, 2005 - AACR
Aberrant activation of Notch receptors has been shown to cause mammary tumors in mice.
We therefore used in situ hybridization to analyze expression of Notch ligands and receptors …

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study

…, A Arnaout, M Brackstone, DR McCready… - Journal of Clinical …, 2015 - ascopubs.org
Purpose An increasing proportion of patients (> 30%) with node-positive breast cancer will
obtain an axillary pathologic complete response after neoadjuvant chemotherapy (NAC). If …

[HTML][HTML] Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer

AW Fyles, DR McCready, LA Manchul… - … England Journal of …, 2004 - Mass Medical Soc
Background We determined the effect of breast irradiation plus tamoxifen on disease-free
survival and local relapse in women 50 years of age or older who had T1 or T2 node-negative …

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

…, D Strongitharm, W Geddie, D McCready - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE It remains a challenge to predict which women with axillary node-negative (ANN)
breast cancer at greatest risk of relapse may benefit most from adjuvant therapy. Increases …

Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk

…, CG Woolcott, EE Sterns, DR McCready… - … biomarkers & prevention, 2000 - AACR
Numerous studies have examined the relationship between organochlorines and breast
cancer, but the results are not consistent. In most studies,organochlorines were measured in …

Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis

…, M Ennis, KI Pritchard, D McCready… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: Weight gain is common during the first year after breast cancer diagnosis. In this
study, we examined clinical factors associated with body size at diagnosis and weight gain …

Cancer-related fatigue and associated disability in post-treatment cancer survivors

…, MK Krzyzanowska, DR McCready… - Journal of Cancer …, 2016 - Springer
Purpose Cancer-related fatigue (CRF) is the most prevalent and distressing symptom among
cancer patients and survivors. However, research on its prevalence and related disability in …

Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients

…, M Varnic, LW Le, W Leong, D McCready - The breast …, 2010 - Wiley Online Library
Lymphedema (LE) is a well‐known postoperative complication after axillary node dissection
(ALND). Although, sentinel lymph node dissection (SLND) involves more focused surgery …